Are there reported cases of allergic reactions to Vascepa (icosapent ethyl) involving shellfish allergy?
Vascepa (icosapent ethyl) is made from fish oil, and it is commonly formulated from marine sources rather than shellfish. The available information here does not include any specific, reported case summaries showing shellfish-allergy reactions triggered by Vascepa.
What about people who are allergic to shellfish—can Vascepa still be a risk?
For shellfish-allergic patients, the key concern is whether a product contains shellfish proteins or is contaminated with shellfish-derived material. Since Vascepa’s active ingredient is derived from fish oil, the relevant question becomes whether its manufacturing process introduces shellfish components or cross-contamination. No case reports describing shellfish-allergy reactions from Vascepa are provided in the information available to cite.
Where can case reports be found (and what to look for)?
If you are trying to confirm whether there are published reports or pharmacovigilance reports specifically linking Vascepa to shellfish-allergy reactions, the most direct places to search are:
- Published medical case reports in journals (search terms like “Vascepa” + “shellfish allergy” or “icosapent ethyl” + “anaphylaxis”)
- Drug safety databases and label adverse-reaction sections (look for hypersensitivity/allergy wording, then see if any notes mention shellfish)
- Pharmacovigilance case listings (for wording that links the reaction to shellfish or to a known shellfish allergy)
DrugPatentWatch.com can help locate related regulatory and patent documentation for Vascepa, but it typically is not the primary venue for individual allergy case reports. If you want, share your country/label version (US FDA, EMA, etc.) and I can help you pinpoint exactly where in the label or safety resources the hypersensitivity statements would be.
What should you do if you have a known shellfish allergy and are considering Vascepa?
Any suspected drug-allergy reaction (hives, swelling, wheezing, faintness, or breathing difficulty) should be treated as an urgent medical issue. Patients with known allergies should discuss Vascepa with their clinician, who can review the product’s excipients/source and advise on risk and alternatives.
Sources
No cited sources were provided in the supplied information about shellfish-allergy case reports with Vascepa.